152 related articles for article (PubMed ID: 2885840)
1. HLA-DR2 subtypes form an additional supertypic family of DR beta alleles.
Lee BS; Rust NA; McMichael AJ; McDevitt HO
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4591-5. PubMed ID: 2885840
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional variability among DQ beta alleles of DR2 subtypes.
Lee BS; Bell JI; Rust NA; McDevitt HO
Immunogenetics; 1987; 26(1-2):85-91. PubMed ID: 2886427
[TBL] [Abstract][Full Text] [Related]
3. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
4. Protein analysis of HLA-DR2.3 haplotype.
Yabe T; Reinsmoen NL; Wu S; Bach FH
Hum Immunol; 1987 Jun; 19(2):127-37. PubMed ID: 3497139
[TBL] [Abstract][Full Text] [Related]
5. cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope.
Wu SK; Yabe T; Madden M; Saunders TL; Bach FH
J Immunol; 1987 May; 138(9):2953-9. PubMed ID: 3571980
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.
Cohen N; Brautbar C; Font MP; Dausset J; Cohen D
Immunogenetics; 1986; 23(2):84-9. PubMed ID: 3007344
[TBL] [Abstract][Full Text] [Related]
7. Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity.
Wu SK; Lu D; Madden M; Liu CP; Miyokawa N; Bach FH; Saunders TL
Hum Immunol; 1990 Apr; 27(4):305-22. PubMed ID: 2318676
[TBL] [Abstract][Full Text] [Related]
8. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
[TBL] [Abstract][Full Text] [Related]
9. Two dimensional gel analysis of HLA-DR2 associated HLA-D clusters.
Nakatsuji T; Moriya K; Tsuji K
Tokai J Exp Clin Med; 1986 May; 11(2):125-31. PubMed ID: 3031855
[TBL] [Abstract][Full Text] [Related]
10. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
11. A new HTC, a PLT and a PLT clone define a split of HLA-DR2 in the Austrian population.
Hajek-Rosenmayr A; Holter W; Mayr WR; Knapp W
Tissue Antigens; 1988 Mar; 31(3):126-35. PubMed ID: 3259738
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
[TBL] [Abstract][Full Text] [Related]
13. T-cell clonal analysis of HLA-DR2 haplotypes.
Reinsmoen NL; Bach FH
Hum Immunol; 1987 Sep; 20(1):13-31. PubMed ID: 3316134
[TBL] [Abstract][Full Text] [Related]
14. MHC class II sequences of an HLA-DR2 narcoleptic.
Lock CB; So AK; Welsh KI; Parkes JD; Trowsdale J
Immunogenetics; 1988; 27(6):449-55. PubMed ID: 3259543
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
16. Electrophoretic analysis of HLA-DR2 molecules isolated from HLA-Dw2 and HLA-Dw12 cell lines.
Takenouchi T; Kasahara M; Ogasawara K; Ikeda H; Ishikawa N; Hawkin S; Wakisaka A; Aizawa M
J Immunogenet; 1985 Feb; 12(1):65-9. PubMed ID: 3876392
[TBL] [Abstract][Full Text] [Related]
17. Cellular and serological subtypes of HLA-DR2.
Freidel AC; Betuel H; Gebuhrer L; Farre A; Lambert J
Tissue Antigens; 1987 Mar; 29(3):129-40. PubMed ID: 2955548
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an HLA-DR beta pseudogene in the DRw52 supertypic group.
Rollini P; Mach B; Gorski J
Immunogenetics; 1987; 25(5):336-42. PubMed ID: 3032786
[TBL] [Abstract][Full Text] [Related]
19. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. II. Distinction between HLA-Dw2 and HLA-Dw12.
Kasahara M; Takenouchi T; Ikeda H; Ogasawara K; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
Immunogenetics; 1983; 18(5):525-36. PubMed ID: 6196285
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide-genotyping as a method of detecting the HLA-DR2 (DRw15)-Dw2, -DR2 (DRw15)-Dw12, -DR4-Dw15, and -DR4-D"KT2" haplotypes in the Japanese population.
Obata F; Ito I; Kaneko T; Ohkubo M; Ishimoto AL; Abe A; Kashiwagi N
Tissue Antigens; 1989 May; 33(5):550-8. PubMed ID: 2799805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
